“Deucravacitinib Long-Term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s118. https://doi.org/10.25251/skin.7.supp.118.